CORC

浏览/检索结果: 共1条,第1-1条 帮助

限定条件                
已选(0)清除 条数/页:   排序方式:
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study 期刊论文
The Lancet Oncology, 2011, 卷号: 12, 期号: 8, 页码: 735-742
作者:  Zhou, Caicun*;  Wu, Yi-Long;  Chen, Gongyan;  Feng, Jifeng;  Liu, Xiao-Qing
收藏  |  浏览/下载:4/0  |  提交时间:2019/12/03


©版权所有 ©2017 CSpace - Powered by CSpace